Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
2.290
-0.110 (-4.58%)
At close: Nov 20, 2024, 4:00 PM
2.250
-0.040 (-1.75%)
After-hours: Nov 20, 2024, 7:55 PM EST
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $44.23 million as of November 21, 2024. Its market cap has decreased by -38.17% in one year.
Market Cap
44.23M
Enterprise Value
51.84M
1-Year Change
-38.17%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $44.23M, a decrease of -83.85%. That is a compound annual growth rate of -44.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 46.36M | -13.43% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Burning Rock Biotech | 47.70M |
| LakeShore Biopharma | 47.70M |
| Protara Therapeutics | 47.65M |
| CollPlant Biotechnologies | 47.45M |
| Affimed | 46.42M |
| SHL Telemedicine | 45.89M |
| CareCloud | 45.55M |
| Reviva Pharmaceuticals Holdings | 45.48M |